Advancing treatments for rare diseases together

October 2017

30Oct

EspeRare, key actor of the Health Valley

Health Valley, TV, report, business model

On the occasion of the 10th anniversary of its TV show Toutes Taxes Comprises (TTC), the Swiss TV channel RTS carried out a report on the Health Valley Switzerland.
EspeRare illustrates, alongside Sophia Genetics and Mindmaze, the diversity, complementarity and dynamics of this ecosystem.

The Health Valley Switzerland, whose name is inspired by Silicon Valley in the USA, is a grouping of biomedical companies from French-speaking Switzerland. The network involves public and private research centres, companies and start-ups working in biomedical technologies, as well as hospitals and clinics. It includes more than 1,000 member companies and 25,000 employees. The Health Valley fosters interaction among its members, and gives international visibility to the biomedical expertise of French-speaking Switzerland.

 

04Oct

Rimeporide clinical study presented at the World Muscle Society

Rimeporide, Duchenne, Duchenne Muscular Dystrophy, DMD, World Muscle Society, Poster

The last advances of the Rimeporide clinical study have been presented at the 22nd World Muscle Society congress, in St Malo. Numerous scientists and physicians have shown interest for this project.

Enrollment into this phase IB clinical trial should be complemented by the end of the year. Full results should be available during the first quarter of 2018. EspeRare is initiating discussions with  worldwide clinicians in order to design the phase II study which should start during 2018, depending  on funding.

Poster presented at the World Muscle Society congress